Geode Capital Management’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $506K | Sell |
229,721
-257,138
| -53% | -$566K | ﹤0.01% | 3549 |
|
|
2025
Q1 | $1.05M | Buy |
486,859
+14,202
| +3% | +$30.7K | ﹤0.01% | 3293 |
|
|
2024
Q4 | $2M | Buy |
472,657
+2,669
| +0.6% | +$11.3K | ﹤0.01% | 3124 |
|
|
2024
Q3 | $5.38M | Buy |
469,988
+281,018
| +149% | +$3.22M | ﹤0.01% | 2722 |
|
|
2024
Q2 | $2.02M | Buy |
188,970
+102,829
| +119% | +$1.1M | ﹤0.01% | 3128 |
|
|
2024
Q1 | $1.32M | Buy |
+86,141
| New | +$1.32M | ﹤0.01% | 3257 |
|